If you are working in any of the following scientific/business topic areas, we encourage you to submit a proposal for a podium presentation. We are especially looking for case studies with new data on the following:


Single Use

  • Standardization and Validation of Single Use Systems
  • Biocompatability Issues
  • Sustainability
  • Integrating with Monitoring Equipment(Process Analytics and Real-Time Monitoring)
  • Integrity Testing / Extractable & Leechable Assessments
  • Supply Chain / Environmental Impacts / Quality Control / Re-Use
  • Overcoming Scabalility Issues from to bench to Overcoming Large Scale Challenges
  • Commercial Manufacturing / Hybrid Approaches

Flexible Facilities

  • Closed Processing / Advantages & Disadvantages of Ballroom Approach
  • Modular Facilities
  • What Flexibility is Required in the Future? Is it Scale Question or a Modality Question? Can it be Both?

Early Stage Process Development and Clinical Manufacturing

  • Transition from R&D to Early Stage Process Development
  • Filling the Bioprocessing Toolbox with New Tools and Technologies
  • The Race from DNA to IND
  • Utilizing High Throughput Screening and Modeling to Improve Predicting at Scale Performance
  • Cell Line Development & Clone Selection
  • Non-mAb and Non-Protein Products
  • New Modalities - New Impurity Challenges?
  • Cell Culture and Media Development Approaches to Optimize Process and Product Quality
  • Innovations at Harvest Step
  • Use of New Purification Technologies
  • Purification Process Development for Non-mAbs
  • Next Generation Unit Operations, Continuous & Integrated Processes

Late Stage Process Development & Commercial Launch Preparation

  • Handoff from Early to Late Stage - What are the Challenges?
  • Improving Process Robustness
  • Continued Process Verification
  • Compressing Timelines for Process Characterization and Process Performance Qualifications
  • Process Validation Strategies from Late Stage to Launch
  • Process Characterization, Control & Validation Strategies to Ensure Robustness
  • Process Intensification
  • Raw Materials
  • Accelerating Late Stage Development
  • Ensuring Successful Process Scale Up, Transfer and Process Performance Qualifications
  • Towards a Commercial Platform Process - Innovation at the Interface of Late Stage PD and Commercial manufacturing

Commercial Manufacturing & Beyond

  • Debottlenecking Operations & Improving Operational Efficiency
  • PAT, Advanced Process Control and Continuous Process Monitoring
  • Continued Process Verification
  • Automation Advances for Capacity Improvements
  • Post Launch Supply Chain Continuity
  • Post Launch Changes & Process Improvements & Optimization
  • Lifecycle Management of Mature Products

Viral Clearance & Safety

  • Viral Risk Mitigation in Upstream Processing
  • New Technologies for Downstream Viral Clearance
  • Viral safety for continuous processing - What are the challenges?
  • Late phase viral clearance requirements


Continuous Processing

  • Early Stage Process Development
  • Late Stage Process Development

Biosimilars - From Early Stage Development to Commercialization

  • What are the Challenges for Biosimilars and Follow-On Biologics During Early Development
  • Challenges for Commercialization

Innovations Leading to Simplification and Cost Reduction - Case Studies of Companies Fostering a Culture of Innovation

  • Use of automation to drive process simplification
  • Innovative planning systems and how they enable cost reduction

Development and Production of Cell & Gene Therapies

  • Challenges with Supply of Cell and Gene Therapy products
  • Innovations in Cell Processing and Process Technologies
  • Ensuring Successful Scale Up and Tech Transfers
  • Overcoming Challenges of Large Scale Manufacturing

Submit a Proposal

Poster Hall Hours

Tuesday, May 10, 2016
3:00 pm - 6:30 pm

Wednesday, May 11, 2016
10:00 am - 6:30 pm

Thursday, May 12, 2016
10:30 am - 2:00 pm

Presentations should be free of commercial bias as well as any references to commercial products and services. All selected faculty are required to disclose the existence of any significant financial interest. Financial interest may affect the consideration of your presentation/proposal application.

You will be notified by the Event Review Committee if your presentation has been selected.

Call for Speakers

Deadline to submit is Friday, October 21, 2016

February 27 - March 2, 2017
Hilton San Francisco Union Square,
San Francisco, CA

BioProcess International West

February 27 - March 2, 2017
Hilton San Francisco Union Square,
San Francisco, CA

Fix the following errors: